The effect of varying molar ratios of potassium-magnesium citrate on thiazide-induced hypokalemia and magnesium loss

Journal of Clinical Pharmacology

Volumn 38, Issue 11, 1998, Pages 1035-1041

  Ruml, Lisa A ^a   Wuermser, Lisa Ann ^a   Poindexter, John ^a   Pak, Charles Y C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE; CITRIC ACID; HYDROCHLOROTHIAZIDE; MAGNESIUM; POTASSIUM; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; DRUG EFFECT; DRUG FORMULATION; DRUG INDUCED DISEASE; ELECTROLYTE BLOOD LEVEL; ELECTROLYTE DISTURBANCE; ELECTROLYTE URINE LEVEL; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN EXPERIMENT; HYPOKALEMIA; MALE; NORMAL HUMAN; TREATMENT OUTCOME;

EID: 0031752930     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/009127009803801108     Document Type: Article

References (5)

1. Pak CYC, Koenig K, Khan R, Haynes S, Padalino P: Physicochemical action of potassium-magnesium citrate in nephrolithiasis. J Bone Miner Res 1992;7:283-287.
2. Ettinger B, Pak CYC, Citron JT, VanGessel A: Potassium magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 1997;158:2069-2073.
3. Koenig K, Padalino P, Alexandrides G, Pak CYC: Bioavailability of potassium and magnesium and citraturic response from potassium-magnesium citrate. J Urol 1991;145:330-334.
4. ++ homeostasis. Semin Nephrol 1987;7:253-262.
5. Sakhaee K, Alpern R, Jacobson HR, Pak CYC: Contrasting effects of various potassium salts on renal citrate excretion. J Clin Endocrinol Metab 1991;72:396-400.